Scinai Immunotherapeutics Ltd (SCNI) — Cash Flow Quality Index
Scinai Immunotherapeutics Ltd (SCNI) has a Cash Flow Quality Index of -0.41x as of March 2026. Operating cash flow of $-1.45 Million is below net income of $3.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Scinai Immunotherapeutics Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Scinai Immunotherapeutics Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Scinai Immunotherapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SCNI capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Scinai Immunotherapeutics Ltd (2024–2024)
Year-by-year earnings quality comparison for Scinai Immunotherapeutics Ltd. For live market cap and the full company financial profile, see Scinai Immunotherapeutics Ltd stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.32x | $-6.33 Million | $4.80 Million | — |